Article Details

New data show Roche's Itovebi significantly extended survival in a certain type of HR ...

Retrieved on: 2025-06-01 00:38:31

Tags for this article:

Click the tags to see associated articles and topics

New data show Roche's Itovebi significantly extended survival in a certain type of HR .... View article details on hiswai:

Excerpt

Basel, 31 May 2025 – Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today positive final results from the overall survival (OS) analysis of the phase ...

Article found on: www.24matins.uk

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo